These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2470195)
41. Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transfer. Mbisa JL; Nikolenko GN; Pathak VK J Virol; 2005 Jan; 79(1):419-27. PubMed ID: 15596835 [TBL] [Abstract][Full Text] [Related]
42. Reverse transcriptase from human immunodeficiency virus: a single template-primer binding site serves two physically separable catalytic functions. Krug MS; Berger SL Biochemistry; 1991 Nov; 30(44):10614-23. PubMed ID: 1718423 [TBL] [Abstract][Full Text] [Related]
43. Human immunodeficiency virus reverse transcriptase substitutes for DNA polymerase I in Escherichia coli. Kim B; Loeb LA Proc Natl Acad Sci U S A; 1995 Jan; 92(3):684-8. PubMed ID: 7531338 [TBL] [Abstract][Full Text] [Related]
44. Mutational analysis of two conserved sequence motifs in HIV-1 reverse transcriptase. Lowe DM; Parmar V; Kemp SD; Larder BA FEBS Lett; 1991 May; 282(2):231-4. PubMed ID: 1709876 [TBL] [Abstract][Full Text] [Related]
45. A single 66-kilodalton polypeptide processed from the human immunodeficiency virus type 2 pol polyprotein in Escherichia coli displays reverse transcriptase activity. Le Grice SF; Zehnle R; Mous J J Virol; 1988 Jul; 62(7):2525-9. PubMed ID: 2453682 [TBL] [Abstract][Full Text] [Related]
46. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors. Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032 [TBL] [Abstract][Full Text] [Related]
47. The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1. Rodgers DW; Gamblin SJ; Harris BA; Ray S; Culp JS; Hellmig B; Woolf DJ; Debouck C; Harrison SC Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1222-6. PubMed ID: 7532306 [TBL] [Abstract][Full Text] [Related]
48. Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli. Farmerie WG; Loeb DD; Casavant NC; Hutchison CA; Edgell MH; Swanstrom R Science; 1987 Apr; 236(4799):305-8. PubMed ID: 2436298 [TBL] [Abstract][Full Text] [Related]
49. Genetic selection in Escherichia coli for active human immunodeficiency virus reverse transcriptase mutants. Kim B Methods; 1997 Aug; 12(4):318-24. PubMed ID: 9245612 [TBL] [Abstract][Full Text] [Related]
50. Structure of human RNase H1 complexed with an RNA/DNA hybrid: insight into HIV reverse transcription. Nowotny M; Gaidamakov SA; Ghirlando R; Cerritelli SM; Crouch RJ; Yang W Mol Cell; 2007 Oct; 28(2):264-76. PubMed ID: 17964265 [TBL] [Abstract][Full Text] [Related]
51. RNase H activity of HIV reverse transcriptases is confined exclusively to the dimeric forms. Restle T; Müller B; Goody RS FEBS Lett; 1992 Mar; 300(1):97-100. PubMed ID: 1372272 [TBL] [Abstract][Full Text] [Related]
52. Ribonuclease H activities associated with viral reverse transcriptases are endonucleases. Krug MS; Berger SL Proc Natl Acad Sci U S A; 1989 May; 86(10):3539-43. PubMed ID: 2471188 [TBL] [Abstract][Full Text] [Related]
53. Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity. Larder BA; Kemp SD; Purifoy DJ Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4803-7. PubMed ID: 2472634 [TBL] [Abstract][Full Text] [Related]
54. Peyssonols A and B, two novel inhibitors of the reverse transcriptases of human immunodeficiency virus types 1 and 2. Loya S; Bakhanashvili M; Kashman Y; Hizi A Arch Biochem Biophys; 1995 Feb; 316(2):789-96. PubMed ID: 7532386 [TBL] [Abstract][Full Text] [Related]
55. Cloning and expression of the complete SIVagm pol region in E. coli. Purification and partial characterization of the reverse transcriptase. Baier M; Behr E; Kurth R; König H Arzneimittelforschung; 1990 Nov; 40(11):1284-7. PubMed ID: 1707622 [TBL] [Abstract][Full Text] [Related]
56. Reconstitution in vitro of RNase H activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase. Hostomsky Z; Hostomska Z; Hudson GO; Moomaw EW; Nodes BR Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1148-52. PubMed ID: 1705027 [TBL] [Abstract][Full Text] [Related]
57. Pyridoxal-5'-phosphate inhibits the polymerase activity of a recombinant RNAase H-deficient mutant of HIV-1 reverse transcriptase. Moen LK; Bathurst IC; Barr PJ AIDS Res Hum Retroviruses; 1992 May; 8(5):597-604. PubMed ID: 1381204 [TBL] [Abstract][Full Text] [Related]
58. Analysis of the ribonuclease H activity of HIV-1 reverse transcriptase using RNA.DNA hybrid substrates derived from the gag region of HIV-1. Mizrahi V Biochemistry; 1989 Nov; 28(23):9088-94. PubMed ID: 2481501 [TBL] [Abstract][Full Text] [Related]
59. Quantitative analysis of RNA cleavage during RNA-directed DNA synthesis by human immunodeficiency and avian myeloblastosis virus reverse transcriptases. DeStefano JJ; Mallaber LM; Fay PJ; Bambara RA Nucleic Acids Res; 1994 Sep; 22(18):3793-800. PubMed ID: 7524028 [TBL] [Abstract][Full Text] [Related]
60. Structural characterization of HIV reverse transcriptase: a target for the design of specific virus inhibitors. Tisdale M; Larder BA; Lowe DM; Stammers DK; Purifoy DJ; Ertl P; Bradley C; Kemp S; Darby GK; Powell KL J Antimicrob Chemother; 1989 Jan; 23 Suppl A():47-54. PubMed ID: 2469675 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]